Taiwan Bio Therapeutics Co., Ltd (TPEX:6892)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
28.10
-0.10 (-0.35%)
May 28, 2026, 1:17 PM CST
Market Cap2.38B -12.2%
Revenuen/a
Net Incomen/a
EPSn/a
Shares Out 84.61M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume264,907
Open28.20
Previous Close28.20
Day's Range27.65 - 29.00
52-Week Range23.60 - 36.05
Beta0.27
Analystsn/a
Price Targetn/a
Earnings Daten/a

About Taiwan Bio Therapeutics

Taiwan Bio Therapeutics Co., Ltd., regenerative medicine company, focuses on the development of new cell medicines. It offers medicines for degenerative diseases, cardiovascular diseases, diabetes complications, and autoimmune diseases. The company was founded in 2014 and is based in Taipei, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 6892
Full Company Profile